Castleview Partners
TMO icon

Castleview Partners’s Thermo Fisher Scientific TMO Stock Holding History

Castleview Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$414K Sell
613
-45
-7% -$26.7K 0.18% 135
2026
Q2 		$330K Sell
658
-2
-0.3% -$960 0.15% 155
2026
Q1 		$324K Sell
660
-18
-3% -$9.8K 0.17% 135
2025
Q4 		$393K Sell
678
-4
-0.6% -$2.26K 0.19% 114
2025
Q3 		$331K Sell
682
-798
-54% -$371K 0.18% 121
2025
Q2 		$600K Buy
1,480
+186
+14% +$77.8K 0.39% 60
2025
Q1 		$644K Sell
1,294
-151
-10% -$81.8K 0.44% 58
2024
Q4 		$755K Sell
1,445
-211
-13% -$116K 0.41% 59
2024
Q3 		$1.02M Buy
1,656
+36
+2% +$21.3K 0.59% 33
2024
Q2 		$896K Buy
1,620
+186
+13% +$107K 0.51% 42
2024
Q1 		$833K Buy
1,434
+441
+44% +$247K 0.47% 51
2023
Q4 		$527K Buy
993
+3
+0.3% +$1.45K 0.37% 59
2023
Q3 		$501K Sell
990
-2
-0.2% -$1.07K 0.46% 44
2023
Q2 		$518K Sell
992
-3
-0.3% -$1.62K 0.47% 40
2023
Q1 		$573K Sell
995
-8
-0.8% -$4.51K 0.51% 45
2022
Q4 		$552K Buy
1,003
+570
+132% +$302K 0.54% 44
2022
Q3 		$220K Sell
433
-1,112
-72% -$622K 0.21% 99
2022
Q2 		$200K Buy
1,545
+1,112
+257% +$612K 0.16% 139
2022
Q1 		$255K Buy
+433
New +$249K 0.16% 132
2021
Q2 		$256K Buy
+507
New +$239K 0.11% 192
2018
Q1 		$201K Buy
+972
New +$204K 0.17% 109

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Quilter Plc
Quilter Plc London, United Kingdom $6.95B AUM 39.67% 1-Year Est. Return
Canoe Financial
Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Sarasin & Partners
Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return
James Hambro & Partners
James Hambro & Partners London, United Kingdom $2.87B AUM 19.92% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Castleview Partners's TMO Position: Q3 2026 in Review

Castleview Partners reduced its Thermo Fisher Scientific (TMO) stake by 6.8% in Q3 2026, selling an estimated $26.7K and leaving 613 shares worth $414K. The position accounts for 0.18% of the portfolio, ranked #135.

Castleview Partners first reported a position in TMO in Q1 2018 and has held it in 21 quarters since. The position peaked at $1.02M in Q3 2024. 750 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Castleview Partners held 613 shares of Thermo Fisher Scientific worth $414K as of Q3 2026.
  • Castleview Partners sold 45 Thermo Fisher Scientific shares in Q3 2026, an estimated $26.7K.
  • Thermo Fisher Scientific made up 0.18% of Castleview Partners's portfolio in Q3 2026, its #135 holding.
  • Castleview Partners first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 21 quarters since.
  • Castleview Partners's Thermo Fisher Scientific position peaked at $1.02M in Q3 2024.
  • 750 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Castleview Partners's 13F filing for Q3 2026, filed 9 Oct 2026.